Panic and hypertension: brothers in arms through 5-HT?

Bago M. , Dean C. ( 2001) Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT(1A) receptors in the RVLM. Am J Physiol Regul Integr Comp Physiol 280: R976—R984

Bago M. , Sprtel B.M. , Dean C. ( 1999) Modulation of sympathetic nerve activity by microinjection of the 5-HT1A receptor agonist 8-OH-DPAT into the rostroventrolateral medulla . J Auton Nerv Syst 76: 127—134

Beckett S. , Marsden C.A. (1997) The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour. J Psychopharmacol 11: 35—40

Bell C.C. , Hildreth C.J. , Jenkins E.J. , Carter C. (1988) The relationship of isolated sleep paralysis and panic disorder to hypertension. J Natl Med Assoc 80: 289—294

Cechetto D.F. , Saper C.B. (1987) Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat. J Comp Neurol 262: 27—45

Davies S J C , Ghahramani P. , Jackson P.R. , Noble T.W. , Hardy P.G. , Hippisley-Cox J. , Yeo W.W. , Ramsay L.E. (1999) Association of Panic Disorder and Panic Attacks with Hypertension. Am J Med 107: 310—316

Davies S J C , Jackson P.R. , Ramsay L.E. , Ghahramani P. , Palmer R.L. , Hippisley-Cox J. (2003) No evidence that panic attacks are associated with the white coat effect in hypertension. J Clin Hypertens 5: 145—152

Davies S J C , Hood S.D. , Argyropoulos S.V. , Morris K. , Bell C. , Witchel H.J. , Jackson P.R. , Nutt D.J. , Potokar J.P. (2006a) Depleting Serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders . J Clin Psychopharm 26: 414—418

Davies S J C , Jackson P.R. , Lewis G. , Hood S.D. , Nutt D.J. (2006b) Panic attacks are more likely to include autonomic symptoms in patients with hypertension than in normotensives - a comparison of symptoms, and factor analysis. ECNP Workshop on Psychophamacology, Nice. 2006. European Neuropsychopharmacology 16: S94—S95

Esler M.D. , Jennings G.L. , Lambert G.W. (1988) Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension. J Hypertens Suppl 6: S494—S496

Ferrier C. , Jennings G.L. , Eisenhofer G. , Lambert G. , Cox H.S. , Kalff V. , Kelly M. , Esler M.D. (1993) Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 11: 1217—1227

Glassman A.H. , O'Connor C.M. , Califf R.M. , Swedberg K. , Schwartz P. , Bigger J.T. Jr , et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701—709

Grassi G. , Kiowski W. (2002) Is the autonomic dysfunction the missing link between panic disorder, hypertension and cardiovascular disease? J Hypertens 20: 2347—2349

Holstege G. (1995) The basic, somatic, and emotional components of the motor system in mammals. In Paxinos G (ed.) The rat nervous system, 2nd ed. Academic Press, San Diego

Jacob C.A. , Cabral A.H. , Almeida L.P. , Magierek V. , Ramos P.L. , Zanoveli J.M. , Landeira-Fernandez J. , Zangrossi H. , Nogueira R.L. (2002) Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacol Biochem Behav 72: 761—766

Johnson P.L. , Lightman S.L. , Lowry C.A. (2004) A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann N Y Acad Sci 1018: 58—64

Katon W. (1984) Panic disorder and somatization. Am J Med 77: 101—106

Katon W. (1986) Panic disorder: epidemiology, diagnosis, and treatment in primary care. J Clin Psychiatry 47 (Suppl. 10): 21—27

Keay K.A. , Bandler R. (2001) Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 25: 669—678

Kerman I.A. , Shabrang C. , Taylor L. , Akil H. , Watson S.J. (2006) Relationship of presympathetic-premotor neurons to the serotonergic transmitter system in the rat brainstem. J Comp Neurol 499: 882—896

Malizia A.L. (1999) What do brain imaging studies tell us about anxiety disorders? J Psychopharmacol 13: 372—378

Mann S.J. (2003) Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am J Hypertens 16: 881—888

Nogueira R.L. , Graeff F.G. (1995) Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav 52: 1—6

Noyes R. , Clancy J. , Hoenk P.R. , Slymen D.J. (1978) Anxiety neurosis and physical illness. Compr Psychiatry 19: 407—413

Polyák J. (2001) How should we manage cardiovascular panic disorder accompanied by hypertension? J Hypertens 19 (Suppl. 2): S64 (Abstract)

Rasmussen A. , Lunde M. , Poulsen D.L. , Sorensen K. , Qvitzau S. , Bech P. ( 2003) A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 44: 216—221

Richerson G.B. (2004) Serotonergic neurons as carbon dioxide sensors that maintain homeostasis. Nat Rev Neurosci 5: 449—461

Shekhar A. , Keim S.R. (1997) The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J Neurosci 17: 9726—9735

Weissman M.M. , Markowitz J.S. , Ouellette R. , Greenwald S. , Kahn J.P. (1990) Panic disorder and cardiovascular/ cerebrovascular problems: results from a community survey. Am J Psychiatry 147: 1504—1508

Wilkinson D.J. , Thompson J.M. , Lambert G.W. , Jennings G.L. , Schwarz R.G. , Jefferys D. , Turner A.G. , Esler M.D. (1998) Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 55: 511—520

Yeragani V.K. , Jampala V.C. , Sobelewski E. , Kay J. , Igel G. ( 1999) Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records. Neuropsychobiology 40: 124—128